1. Home
  2. IVVD vs XNET Comparison

IVVD vs XNET Comparison

Compare IVVD & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
    SELLHOLDBUYas of 3 days ago
  • XNET
    SELLHOLDBUYas of 3 days ago
  • Stock Information
  • Founded
  • IVVD 2020
  • XNET 2003
  • Country
  • IVVD United States
  • XNET China
  • Employees
  • IVVD N/A
  • XNET N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • XNET Computer Software: Prepackaged Software
  • Sector
  • IVVD Health Care
  • XNET Technology
  • Exchange
  • IVVD Nasdaq
  • XNET Nasdaq
  • Market Cap
  • IVVD 53.0M
  • XNET 131.8M
  • IPO Year
  • IVVD 2021
  • XNET 2014
  • Fundamental
  • Price
  • IVVD $0.56
  • XNET $2.05
  • Analyst Decision
  • IVVD Strong Buy
  • XNET
  • Analyst Count
  • IVVD 4
  • XNET 0
  • Target Price
  • IVVD $7.89
  • XNET N/A
  • AVG Volume (30 Days)
  • IVVD 1.0M
  • XNET 150.3K
  • Earning Date
  • IVVD 11-14-2024
  • XNET 11-14-2024
  • Dividend Yield
  • IVVD N/A
  • XNET N/A
  • EPS Growth
  • IVVD N/A
  • XNET 146.84
  • EPS
  • IVVD N/A
  • XNET 0.23
  • Revenue
  • IVVD $11,564,000.00
  • XNET $359,611,000.00
  • Revenue This Year
  • IVVD N/A
  • XNET N/A
  • Revenue Next Year
  • IVVD $486.65
  • XNET N/A
  • P/E Ratio
  • IVVD N/A
  • XNET $9.06
  • Revenue Growth
  • IVVD N/A
  • XNET 99.13
  • 52 Week Low
  • IVVD $0.40
  • XNET $1.45
  • 52 Week High
  • IVVD $5.20
  • XNET $2.41
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 48.86
  • XNET 50.43
  • Support Level
  • IVVD $0.43
  • XNET $1.99
  • Resistance Level
  • IVVD $0.57
  • XNET $2.15
  • Average True Range (ATR)
  • IVVD 0.07
  • XNET 0.10
  • MACD
  • IVVD 0.02
  • XNET -0.00
  • Stochastic Oscillator
  • IVVD 76.12
  • XNET 44.64

Stock Price Comparison Chart: IVVD vs XNET

IVVD
XNET
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025051015202530354045505560IVVD VS XNET

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use